---
title: "10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference | TXG Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/271030062.md"
description: "10x Genomics, Inc. (Nasdaq: TXG) will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, at 8:15 a.m. PT. A live webcast of the presentation will be available on the company's website and archived for 30 days. 10x Genomics specializes in single cell and spatial biology, providing integrated research solutions that aid in understanding complex biological systems, contributing to advancements in health and disease research."
datetime: "2025-12-29T13:05:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/271030062.md)
  - [en](https://longbridge.com/en/news/271030062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/271030062.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/271030062.md) | [繁體中文](https://longbridge.com/zh-HK/news/271030062.md)


# 10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference | TXG Stock News

, /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time.

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.

**About 10x Genomics**

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.

**Disclosure Information**

10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

**Contacts**

Investors: investors@10xgenomics.com

Media: media@10xgenomics.com

SOURCE 10x Genomics, Inc.

### Related Stocks

- [10x Genomics, Inc. (TXG.US)](https://longbridge.com/en/quote/TXG.US.md)

## Related News & Research

- [A Look At Torex Gold Resources (TSX:TXG) Valuation After Updated Reserves And Los Reyes Addition](https://longbridge.com/en/news/281131745.md)
- [10x Genomics Seen As Key Player In AI-Driven Biological Data Buildout](https://longbridge.com/en/news/281229647.md)
- [Innate Pharma to Participate in the Kempen Life Sciences Conference | IPHA Stock News](https://longbridge.com/en/news/281605166.md)
- [Royal Gold Presenting at the Mining Forum Europe 2026 Conference | RGLD Stock News](https://longbridge.com/en/news/281580399.md)
- [Vinyl Group Secures $10m Chairman-Backed Loan to Fund Val Morgan Digital Deal](https://longbridge.com/en/news/281078528.md)